Kristine Kucera, PA-C, MPAS, DHS Psoriatic Arthritis (PsA) affects up to one third of people with psoriasis (PsO). Evidence indicates that diagnosis of PsO may precede the diagnosis of PsA by up to a decade. Currently, most cases of PsA are diagnosed based on...
Kristine Kucera, PA-C, MPAS, DHS The first interchangeable biosimilar for AbbVie’s Humira (adalimumab) officially entered the US market this month. Cyltezo (adalimumab-adbm) from Boehringer Ingelheim is now commercially available. As a reminder, biosimilars...
Kristine Kucera, PA-C, MPAS, DHS Treating pediatric patients with inflammatory skin disease often can be challenging. Without published treatment guidelines, clinicians may be uncomfortable prescribing methotrexate (MTX) in this population. To address this...
Kristine Kucera, PA-C, MPAS, DHS The National Rosacea Society (NRS) is set to introduce Seals of Acceptance for products that are safe and suitable for individuals with rosacea. This initiative aims to alleviate the challenges faced by those living with the...
Kristine Kucera, PA-C, MPAS, DHS June is National Acne Awareness Month. Let’s have a little fun. Although not from a scientific journal, I came across this article discussing some of the home remedies that patients have tried to improve their acne. I am...
Kristine Kucera, PA-C, MPAS, DHS Acne is one of the most common skin conditions we, as dermatology providers, treat. While acne usually begins in puberty and is considered a disease of adolescence, it often presents in adults. In fact the prevalence of adult...
